National free service hotline:4008365133

Preparation product

Your current position:Home > Preparation product
  • ribavirin buccal tablets
Detailed description

Ribavirin Buccal Tablets product summary

Please use it under the guidance of a doctor


[drug name]

Generic name: Ribavirin Buccal Tablets

Buccal Tablets Ribavirin

Chinese Pinyin: Han Pian Libaweilin

[properties] this product is light yellow buccal tablets; aroma; taste sweet.

[indications] suitable for respiratory tract virus caused by viral pneumonia and bronchitis, skin herpes virus infection.

[Specification] 20mg

[usage and dosage]

Oral

1 viral respiratory tract infection and skin herpes virus infection: adult daily 400 ~ 1000mg (20 ~ 50), the course of treatment for 7 to 14 days.

2 children daily according to body weight 10mg/kg, points 4 times to take, the course of treatment 7 days.6 years old the following children oral dosage is undecided.

[adverse reactions]

Common adverse reactions included anemia, fatigue after discontinuation of the drug disappeared. A rare adverse reactions are tired, headache, insomnia, loss of appetite, nausea, vomiting, mild diarrhea, constipation and other and can cause red blood cells, white blood cells and hemoglobin decline.

[taboo] allergy to this product, pregnant women disabled.

[note]

1 severe anemia, abnormal liver function with caution.

2 for the diagnosis of interference: oral administration of the product after the rise of blood bilirubin can be as high as 25%. large dose can cause a decrease in hemoglobin content.

3 as early as possible drug use. Respiratory tract infection with viral pneumonia in the first 3 days to the general effective. This product is not suitable for patients without laboratory diagnosis of respiratory infection with the virus.

4 long and large doses of liver function, blood adverse reaction.

[pregnant women and breastfeeding women medication]

1 this product has a strong effect, the rabbit's daily dose of 1mg/kg that can cause fetal damage, it is forbidden to use for pregnant women and pregnant women (this product in vivo elimination is very slow, 4 weeks after stopping drug can not be completely removed).

2. A small amount of drugs are excreted by the milk and the mother and the second generation animals are toxic, so breast-feeding women during the treatment need to suspend breastfeeding, the milk should be discarded. Due to there self limited, so the product is not used to this kind of case having the lactating women respiratory syncytial virus infection.

Children under 6 years of age children medication is not clear.

[elderly medication] elderly people do not recommend application.

High dose application can cause heart damage, for patients with respiratory diseases (chronic obstructive pulmonary disease or asthma) can cause dyspnea, chest pain and so on.

[storage] seal preservation.

[packing] plastic packaging, 12 tablets / plate, 24 / box.

[Effective] 24 months

[executive standard] < Chinese Pharmacopoeia >2015 version two

[approval] Zhunzi H19993875